Suki Raises $90M to Expand AI Agent Capabilities
Suki raised $90M Series E led by Healthier Capital to expand its AI agent capabilities across clinical, financial, and operational workflows.

The big picture: Suki, a healthcare artificial intelligence company, has secured $90 million in Series E financing to expand its AI agent capabilities across clinical, financial, and operational workflows for health systems and healthcare technology companies.
Why it matters:
- Streamlined Integration: Healthcare providers face significant challenges integrating AI tools into existing clinical systems without creating additional disconnected applications or complicating workflows.
- Operational Efficiency: Suki’s platform aims to reduce administrative workloads, documentation time, and work completed outside regular hours, addressing a growing operational challenge.
- Financial Impact: KLAS-validated findings indicate an average monthly financial impact exceeding $2,600 per provider, alongside reductions in clinical documentation time.
How it works:
- Dual Offering: Suki provides ‘Suki for Clinicians’ for direct AI capabilities to healthcare professionals and ‘Suki for Partners’ to embed its technology through SDKs and APIs for other health tech companies.
- Workflow Integration: The platform supports clinical documentation, decision-making, and administrative processes, allowing healthcare organizations to access capabilities through existing technology platforms.
- Clinical Knowledge Integration: The recently introduced ‘Ask’ feature incorporates clinical knowledge from Wolters Kluwer’s UpToDate Expert AI directly into clinicians’ workflows, providing reference information without switching applications.
The catch: The success of AI integration in healthcare depends heavily on effective implementation and user adoption within complex, often fragmented, health systems. While Suki aims for seamless integration, the challenge of avoiding ‘disconnected applications’ remains significant. Competition in the healthcare AI sector is also intensifying, requiring continuous innovation to maintain market leadership and demonstrate clear return on investment beyond initial documentation efficiencies.
Key Facts
- Company: Suki
- Amount: $90M
- Round: Series E
- Investors: Healthier Capital (lead), Crosslink Capital, Hercules Capital, Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, Zoom Ventures
- Founder: Punit Soni
- Sector: Healthcare AI Agents
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.